Chris Rivera has been named president of the Washington Biotechnology and Biomedical Association, succeeding retiring president Jack Faris.
Rivera, a Washington state resident since 1985, will begin his duties on Jan. 1, 2009. Most recently Rivera was founder and CEO of Hyperion Therapeutics. Prior to this, he was senior vice president of commercial operations at Tercica. Rivera also served as senior vice president at Genzyme Therapeutics, and has worked for Centocor and Cephalon.
He holds an MS degree in audiology from the University of Oklahoma Health Sciences Center, and a BS in business from Northwestern Oklahoma State University.
Konstantinos Andrikopoulos has joined RXi Pharmaceuticals as vice president, legal counsel, and chief intellectual property counsel.
Prior to joining RXi, Andrikopoulos spent six years at Shire Human Genetic Therapies, a wholly owned subsidiary of Shire Pharmaceuticals, most recently as senior patent counsel. Andrikopoulos also worked for five years at Wolf, Greenfield, & Sacks, a Boston-based IP law firm.
He holds a law degree from Suffolk University Law School in Boston; a PhD in biomedical sciences from the City University of New York (through Mount Sinai School of Medicine’s Graduate School of Biological Sciences program); and a BSc in biophysics from the University of East London. Andrikopoulos also was a postdoc at Massachusetts General Hospital, Harvard Medical School.
Foley Lardner said last week that three attorneys with life sciences and intellectual property specialties have joined Foley’s San Diego office from Heller Ehrman.
Richard Kaufman joins Foley’s IP and business law group as a partner, with a practice focus on the life sciences industry. Kaufman has also served as general counsel and consultant for Trega Biosciences.
David Charapp joins Foley’s business department as special counsel. Prior to his work at Heller, he served as associate general counsel with Santarus and Kosan Biosciences, and in private practice.
Leslie Overman will join Foley’s IP department as a registered patent attorney. He is a PhD biochemist with experience as a staff scientist for several biotechnology companies, Foley said.
Foley Hoag announced this week that it has hired Susie Ahn, former director of federal government relations for the Biotechnology Industry Organization, as a health policy specialist in Foley’s government strategies group.
Prior to her work for BIO, Ahn served as a senior legislative assistant for Congressman Mike Honda (D-Calif.). She also served in a similar capacity for Congressman Xavier Becerra (D-Calif.).
Ahn holds a BA from the University of California, Irvine, and is expected to receive her JD from George Washington University Law School in 2009.
Cambridge, Mass.-based law firm Lowrie, Lando and Anastasi said this week that Matthew Ambros, David Roccio, David Lu, and Anne Reynolds have joined the firm; and that Allyson Hatton has become an associate at the firm.
Ambros was previously a law clerk to the Justices of the Superior Court of Massachusetts. He will focus his practice on all aspects of intellectual property litigation, LL&A said. Ambros was recently admitted to practice law in Massachusetts after graduating from Northwestern University School of Law. He also holds a BA degree in genetics, cell, and developmental biology from Dartmouth College.
Roccio was previously a summer associate at LL&A, and will focus his practice on patent counseling and prosecution in various technologies. Roccio is registered to practice before the United States Patent and Trademark Office. He graduated from Franklin Pierce Law Center, and received a BS degree in electrical engineering from the University of New Hampshire.
Lu is a technology specialist at LL&A and focuses on a variety of IP matters. He was previously a postdoc at Dana Farber Cancer Institute and Harvard Medical School. Lu also received his PhD in molecular genetics and microbiology from Duke University Medical Center.
Reynolds is also a technology specialist at LL&A, and focuses her practice on a variety of intellectual property matters in the areas of organic and inorganic chemistry, biochemistry, molecular biology, as well as other areas of biotechnology and pharmaceuticals. Reynolds was previously a postdoc at the Massachusetts Institute of Technology, and received her PhD from the University of Minnesota.
Hatton was previously a technology specialist at LL&A, and has experience in patent prosecution, general client counseling, and patent portfolio construction in the areas of cell biology, biochemistry, molecular biology, immunology, and genetics. She was a postdoc of the Damon Runyon-Walter Winchell Foundation at Dana Farber and Harvard Medical. She graduated from Suffolk University Law School and holds a PhD in biology from Carnegie Mellon University.